Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway

• Main Authors: Fan Wang (Author), Chang Liu (Author), LingZhi Ren (Author), YanYang Li (Author), HongMei Yang (Author), Yang Yu (Author), WeiPing Xu (Author)
• 格式: 圖書
• 出版: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

AbstractContext Sanziguben (SZGB) is an empirical prescription used in traditional Chinese medicine to treat diabetic nephropathy (DN). As an abundant and primarily effective component of SZGB, Sanziguben polysaccharides (SZP) can be digested by flora to generate biological activity.Objective Our st...